- [What place for DNA microarray in inflammatory diseases?]V Devauchelle
Unité Inserm 567, Institut Cochin, Pavillon Hardy A, 1 étage, 27 rue du Faubourg Saint Jacques, 75674 Paris, France
Rev Med Interne 25:732-9. 2004..In few years it has become an obligatory step in massive gene expression study. The enormous quantity of results generated and the new way of thinking allowed make this kind of study a true revolution...
- DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targetsV Devauchelle
Institut Cochin, Paris, France
Genes Immun 5:597-608. 2004..It is proposed that such an approach allows valuable diagnosis/prognostics tools in RA to be established and potential targets for combating the disease to be identified...
- BAFF and rheumatic autoimmune disorders: implications for disease management and therapyS Bosello
Laboratory of Immunology, Medical School, Brest, France
Int J Immunopathol Pharmacol 20:1-8. 2007..Recent works suggest that antagonizing the protein (or competing for its receptors) is relevant to the treatment. Advances in our understanding of the BAFF system offers the opportunity to improve our therapeutic approach...
- Is hypocomplementemia useful for diagnosing or predicting extra-articular manifestations in patients with rheumatoid arthritis?A Saraux
Rheumatology Department, CHU de Brest, France
Joint Bone Spine 68:487-92. 2001..The objective of this study was to evaluate whether complement assays are useful in diagnosing or predicting SEAMs of RA...
- B cell-ablative therapy: where are we now?A Bordron
Int J Immunopathol Pharmacol 20:655-9. 2007..The efficacy in different diseases, and the emergence of new anti-CD20 Abs raise many questions. Thus, their detailed understanding can lead to a better issue for inhibition of immune responses...